Aiming to further understand how targeting the EGFR-binding protein SLC7A11 influences MHC-I antigen presentation and induces T-cell mediated cytotoxicity in NPC cells, we sought to elucidate the therapeutic mechanisms of sorafenib in NPC. The gene discussed is SLC7A11; the disease is nasopharyngeal carcinoma.